In2C Global Pharma Private Limited

Provides marketing and consulting services for pharmaceutical businesses in India and abroad.

2013 | Rangareddy, Telangana (India) | Active
Last Updated:

In2C Global Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 12.43%
  • Profit Growth -0.97%
  • Ebitda -1.82%
  • Net Worth 93.78%
  • Total Assets 109.46%

About In2C Global Pharma

In2c Global Pharma Private Limited (IGPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 2013 and has a history of 11 years and five months. Its registered office is in Rangareddy, Telangana, India.

The Company is engaged in the Business Outsourcing Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Venkat Cherala and Sridevi Cherala serve as directors at the Company.

Company Details

  • Location

    Rangareddy, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233TG2013PTC091166

  • Company No.

    091166

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Nov 2013

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Business Outsourcing
Company report

In2c Global Pharma Private Limited

Explore comprehensive data for In2c Global Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at In2C Global Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Venkat Cherala Country flag representing In Director 21-Nov-2013Current
Sridevi Cherala Country flag representing In Director 03-Jan-2020Current

Financial Performance of In2C Global Pharma.

In2C Global Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 12.43% increase. The company also saw a slight decrease in profitability, with a 0.97% decrease in profit. The company's net worth Soared by an impressive increase of 93.78%.

In2C Global Pharma revenue growth over time
In2C Global Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
12.43%
Revenue from Operations
12.43%
Total Assets
109.46%
Profit or Loss
-0.97%
Net Worth
93.78%
EBITDA
-1.82%

What is the Ownership and Shareholding Structure of In2C Global Pharma?

In 2020, In2C Global Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at In2C Global Pharma?

Unlock and access historical data on people associated with In2C Global Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for In2C Global Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of In2C Global Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped In2C Global Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on In2C Global Pharma

Recent activity within the organization

  • Annual General Meeting

    In2C Global Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    In2C Global Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Sridevi Rao Cherala was appointed as a Director was appointed as a Director on 03 Jan 2020 & has been associated with this company since 5 years 4 months .

  • Director Appointment

    Venkat Narayan Rao Cherala was appointed as a Director was appointed as a Director on 21 Nov 2013 & has been associated with this company since 11 years 5 months .

  • Company Incorporation

    In2C Global Pharma Private Limited was registered on 21 Nov 2013 with Roc Hyderabad & aged 11 years 5 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of In2C Global Pharma Private Limited?

    In2C Global Pharma Private Limited was incorporated on 21 Nov 2013.

  • What is authorized share capital and paid-up capital of In2C Global Pharma Private Limited?

    The authorized share capital of In2C Global Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of In2C Global Pharma Private Limited?

    Currently 2 directors are associated with In2C Global Pharma Private Limited.

    • Venkat Narayan Rao Cherala
    • Sridevi Rao Cherala

  • What is the registered address of In2C Global Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of In2C Global Pharma Private Limited is 83 Whisper Valley, Raidurg India, Hyderabad, Telangana, 500008.

  • What is the corporate identification number (CIN) and company number of In2C Global Pharma Private Limited?

    The corporate identification number (CIN) of In2C Global Pharma Private Limited is U24233TG2013PTC091166 and the company number is 091166 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for In2C Global Pharma Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for In2C Global Pharma Private Limited has risen by 12.43%.

  • What change has been observed in the net worth of In2C Global Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of In2C Global Pharma Private Limited has experienced an upsurge of 93.78%.

  • When was the last Balance Sheet of In2C Global Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for In2C Global Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Business & IT Consulting